Severity of acute coronary syndrome is predicted by interactions between fibrinogen concentrations and polymorphisms in the GPIIIa and FXIII genes [10]

Journal of Thrombosis and Haemostasis

Volumn 4, Issue 4, 2006, Pages 909-912

  Odeberg, J ^a,d   Freitag, M ^b,e   Odeberg, H ^c   Rastam L ^e   Lindblad, U ^e,f  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b HELSINGBORG HOSPITAL   (Sweden)

^c BLEKINGE HOSPITAL   (Sweden)

^d ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^e LUND UNIVERSITY HOSPITAL   (Sweden)

^f Skaraborgs Institutet   (Sweden)

Author keywords

Factor XIII; Fibrinogen; Glycoprotein IIb IIIa; Polymorphism; Thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 13; CHOLESTEROL; FIBRIN; FIBRINOGEN; FIBRINOGEN RECEPTOR;

ACUTE CORONARY SYNDROME; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DISEASE SEVERITY; DNA POLYMORPHISM; ELECTROCARDIOGRAM; EXERCISE TEST; FIBRINOLYSIS; GENETIC SUSCEPTIBILITY; GENOTYPE; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; IN VITRO STUDY; LETTER; PREDICTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; RISK ASSESSMENT; RISK FACTOR; SIGNAL TRANSDUCTION; SMOKING; SYMPTOMATOLOGY; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOSIS; UNSTABLE ANGINA PECTORIS;

ACUTE DISEASE; ADULT; AGED; BLOOD PLATELETS; CORONARY ARTERIOSCLEROSIS; FACTOR XIII; FEMALE; FIBRINOGEN; HUMANS; INTEGRIN BETA3; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SYNDROME;

EID: 33644983516     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2006.01835.x     Document Type: Letter

References (20)

1. Cannon P, Braunwald E. Unstable angina and non-ST elevation myocardial infarction. In: Zipes D, Libby P, Bonow R, Braunwald E, eds. Heart Disease: A Textbook of Cardiovascular Medicine. Philadelphia: Elsevier Saunders, 2005: 1243-73.
2. Feng D, Lindpaintner K, Larson MG, Rao VS, O'Donnell CJ, Lipinska I, Schmitz C, Sutherland PA, Silbershatz H, D'Agostino RB, Muller RH, Levy D, Tofler GH. Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: The Framingham Offspring Study. Arterioscler Thromb Vasc Biol 1999; 19: 1142-7.
3. Vijayan KV, Goldschmidt-Clermont PJ, Roos C, Bray PF. The Pl(A2) polymorphism of integrin beta(3) enhances outside-in signaling and adhesive functions. J Clin Invest 2000; 105: 793-802.
4. Feng D, Lindpaintner K, Larson MG, O'Donnell CJ, Lipinska I, Sutherland PA, Mittleman M, Muller JE, D'Agostino RB, Levy D, Tofler GH. Platelet glycoprotein IIIa Pl(a) polymorphism, fibrinogen, and platelet aggregability: The Framingham Heart Study. Circulation 2001; 104: 140-4.
5. Lim BC, Ariens RA, Carter AM, Weisel JW, Grant PJ. Genetic regulation of fibrin structure and function: Complex gene-environment interactions may modulate vascular risk. Lancet 2003; 361: 1424-31.
6. Ariens RA, Philippou H, Nagaswami C, Weisel JW, Lane DA, Grant PJ. The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure. Blood 2000; 96: 988-95.
7. Alexander RW, Pratt CM, Roberts R. Diagnosis and management of patients with acute myocardial infaction. In: Alexander RW, Schlant RC, Fuster V, eds. Hurst's The Heart, 9th edn. New York: McGraw-Hill, 1998: 1345-1433.
8. Holmberg K, Persson ML, Uhlen M, Odeberg J. Pyrosequencing analysis of thrombosis-associated risk markers. Clin Chem 2005; 51: 1549-52.
9. Kohler HP, Stickland MH, Ossei-Gerning N, Carter A, Mikkola H, Grant PJ. Association of a common polymorphism in the factor XIII gene with myocardial infarction. Thromb Haemost 1998; 79: 8-13.
10. Catto AJ, Kohler HP, Coore J, Mansfield MW, Stickland MH, Grant PJ. Association of a common polymorphism in the factor XIII gene with venous thrombosis. Blood 1999; 93: 906-8.
11. Weiss EJ, Bray PF, Tayback M, Schulman SP, Kickler TS, Becker LC, Weiss JH, Gerstenblith G, Goldschmidt-Clermont PJ. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 1996; 334: 1090-4.
12. Bray PF, Cannon CP, Goldschmidt-Clermont P, Moye LA, Pfeffer MA, Sacks FM, Braunwald E. The platelet Pl(A2) and angiotensin-converting enzyme (ACE) D allele polymorphisms and the risk of recurrent events after acute myocardial infarction. Am J Cardiol 2001; 88: 347-52.
13. Ridker PM, Hennekens CH, Schmitz C, Stampfer MJ, Lindpaintner K. PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis. Lancet 1997; 349: 385-8.
14. Herrmann SM, Poirier O, Marques-Vidal P, Evans A, Arveiler D, Luc G, Emmerich J, Cambien F. The Leu33/Pro polymorphism (PlA1/PlA2) of the glycoprotein IIIa (GPIIIa) receptor is not related to myocardial infarction in the ECTIM Study. Etude Cas-Temoins de l'Infarctus du Myocarde. Thromb Haemost 1997; 77: 1179-81.
15. Di Castelnuovo A, de Gaetano G, Donati MB, Iacoviello L. Platelet glycoprotein receptor IIIa polymorphism PLA1/PLA2 and coronary risk: A meta-analysis. Thromb Haemost 2001; 85: 626-33.
16. Burr D, Doss H, Cooke GE, Goldschmidt-Clermont PJ. A meta-analysis of studies on the association of the platelet PlA polymorphism of glycoprotein IIIa and risk of coronary heart disease. Stat Med 2003; 22: 1741-60.
17. Di Castelnuovo A, de Gaetano G, Benedetta Donati M, Iacoviello L. Platelet glycoprotein IIb/IIIa polymorphism and coronary artery disease: implications for clinical practice. Am J Pharmacogenomics 2005; 5: 93-9.
18. Boekholdt SM, Peters RJ, de Maat MP, Zwinderman AH, van Der Wall EE, Reitsma PH, et al. Interaction between a genetic variant of the platelet fibrinogen receptor and fibrinogen levels in determining the risk of cardiovascular events. Am Heart J 2004; 147: 181-6.
19. Senti M, Aubo C, Bosch M, Pavesi M, Pena A, Masia R, Marrugat J. Platelet glycoprotein IIb/IIIa genetic polymorphism is associated with plasma fibrinogen levels in myocardial infarction patients. The REGICOR Investigators. Clin Biochem 1998; 31: 647-51.
20. Butt C, Zheng H, Randell E, Robb D, Parfrey P, Xie YG. Combined carrier status of prothrombin 20210A and factor XIII-A Leu34 alleles as a strong risk factor for myocardial infarction: Evidence of a gene-gene interaction. Blood 2003; 101: 3037-41.